Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
980.00    23.00 (2.40%)
Bid:
979.50
Ask:
981.50
Spread: 2.00 (0.204%)
Market Cap: £883.61m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Form 8.3 - Gamma Communications plc

13 Apr 2026 11:43

Form 8.3 - Gamma Communications plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Jupiter Fund Management Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of Offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeGamma Communications plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held: For an opening position disclosure, state the latest practicable date prior to the disclosure10th April 2026
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.25p ordinary
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:6,852,9137.53%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:6,852,9137.53%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:None
Details, including nature of the rights concerned and relevant percentages:None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
OrdinaryPurchase36,2958.26
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
NONE    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
None   

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:13th April 2026
Contact name:Christopher Akuwudike
Telephone number:0203 817 1494

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights
28th Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20235:34 pmRNSHolding(s) in Company
21st Dec 20235:33 pmRNSHolding(s) in Company
13th Dec 20235:35 pmRNSDirector/PDMR Shareholding
13th Dec 202312:34 pmRNSIssue of Equity
5th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20234:13 pmRNSHolding(s) in Company
15th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSBlock listing Interim Review
1st Nov 202311:13 amRNSTotal Voting Rights
13th Oct 20233:59 pmRNSDirector/PDMR Shareholding
2nd Oct 20232:34 pmRNSTotal Voting Rights
14th Sep 20234:12 pmRNSIssue of Equity
14th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 20232:25 pmRNSHolding(s) in Company
15th Aug 20234:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSTrading Statement
1st Aug 20237:00 amRNSTotal Voting Rights
13th Jul 20232:04 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:11 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:43 amRNSTotal Voting Rights
13th Jun 20235:03 pmRNSDirector/PDMR Shareholding
9th Jun 202312:35 pmRNSDirector/PDMR Shareholding
1st Jun 20232:19 pmRNSTotal Voting Rights - Replacement
1st Jun 202312:17 pmRNSTotal Voting Rights
30th May 202310:05 amRNSBlock Listing Application
25th May 20237:00 amRNSAppointment of Chair
23rd May 20234:12 pmRNSDirector/PDMR Shareholding
17th May 20235:08 pmRNSCommittee Composition
17th May 20234:25 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Trading update
15th May 202311:46 amRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSDirector/PDMR Shareholding
9th May 20239:44 amRNSBlock listing Interim Review
2nd May 202310:09 amRNSTotal Voting Rights
20th Apr 20234:33 pmRNSPublication of Notice of AGM
13th Apr 202311:31 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202311:42 amRNSDirector/PDMR Shareholding
28th Mar 202312:43 pmRNSHolding(s) in Company
21st Mar 20237:01 amRNSFinal Results
21st Mar 20237:00 amRNSChair succession planning
16th Mar 20237:00 amRNSDirectorate Change
14th Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20232:01 pmRNSTotal Voting Rights
1st Mar 20239:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.